PrecisionLife

Private

OxfordHealthcare & Life Scienceshttps://precisionlife.com/

Last Round

Grant

Feb 20, 2025

Total Funding Raised

$3.48M

Company Overview

PrecisionLife is a techbio company that provides an AI-driven precision medicine platform for drug discovery and the treatment of chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Precision Medicine, Medical AI, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service, Government Contracts

AI Layer

Infrastructure

Keywords

drug target discoverycombinatorial analyticspatient stratificationAI drug discoveryprecision medicinedrug repositioningdrug repurposingtechbiobiomarker discoverycausal AIprecision diagnosticschronic disease researchindication extensionclinical trial stratificationgenomic data analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PrecisionLife Comps

Public and private peers based on sector, stage, and business model.

PrecisionLife comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PrecisionLife Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Feb 20, 2025
Grant	Dec 15, 2023
Series A	Jan 31, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Rowan Gardner

Chief Business And Investment Officer, Co Founder

Founding Team

Steve Gardner

CEO

Executive Team

PrecisionLife Investors

Notable investors and investment history

PrecisionLife investors
Investor	Rounds
European Innovation Council	Grant
Grosvenor Food & AgTech	Series A
Innovate UK	Grant
University of Edinburgh	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 20, 2026
Monthly visitors grew 299% MoM, reaching 10.7K.
Jun 1, 2025
Monthly visitors increased 53% MoM, reaching 8.7K.

View all signals

PrecisionLife Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PrecisionLife Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PrecisionLife's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford

Employee Range33

Year Founded2013

Last FundingFeb 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.